An interventional study of pursed lip breathing and Alternate Nostril breathing: in COPD Grade I, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-15.
Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan — 28 open to participants now, 28 under way, 1 of them phase 3. Pulmonary Disease, Chronic Obstructive · Pakistan.
Among the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan, this one is the 52nd largest by planned enrollment of the 75 interventional ones that give a count, is one of 12 that started in 2026, is one of 72 with no phase, reaches primary completion later than 17 of the 27 other live ones, and was the 69th registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →28 of the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan are open now. Recruiting first, the newest first:
Rashid Latif Medical College · Sites in Pakistan
Ages 20–65
Riphah International University · Sites in Pakistan
Ages 40–60
Foundation University Islamabad · Sites in Pakistan
Ages 40–65
Foundation University Islamabad · Sites in Pakistan
Ages 40–75
Foundation University Islamabad · Sites in Pakistan
Ages 40–70
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 40 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
78 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 12 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 48 across the 75 interventional studies, 140 across the 3 observational. Of the 47 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 78 have an industry lead sponsor. The 10 most frequent:
Foundation University Islamabad is the lead sponsor of 255 studies on the registry; 142 are open to participants now.
Foundation University Islamabad has 6 studies filed under Pulmonary Disease, Chronic Obstructive — fewer than ten, so there is no comparison to draw.
3 of the studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07875036Foundation University IslamabadComparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease | 2026-12-15 |
| NCT07875049Foundation University IslamabadAdditional Effects of Flutter With Conventional Chest Physiotherapy on Peak Expiratory Flow Rate and Chest Expansion in Post CABG Patients With COPD | 2026-12-20 |
| NCT07708337Capital Development Authority (CDA)Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder characterized by airflow limitation, breathlessness, and reduced quality of life. Breathing exercises are commonly used in pulmonary rehabilitation to improve respiratory efficiency and functional capacity. Among these techniques, pursed lip breathing (PLB) helps slow expiration, reduce air trapping, and improve ventilation, while alternate nostril breathing (ANB), a yogic breathing technique, may enhance respiratory control and relaxation.
The purpose of this study is to determine the effects of pursed lip breathing alone compared with the combined effect of pursed lip breathing and alternate nostril breathing on pulmonary function and quality of life in patients with Grade I COPD. This randomized controlled trial will include approximately 40 participants diagnosed with mild COPD. The participants will be divided into two groups: one group will perform pursed lip breathing exercises, while the other group will perform a combination of pursed lip breathing and alternate nostril breathing.
Pulmonary function tests and quality of life assessments will be used as outcome measures to evaluate the effectiveness of these interventions. The study aims to determine whether combining both breathing techniques provides greater improvement in respiratory function and patient well being than pursed lip breathing alone. The findings may contribute to developing more effective physiotherapy based pulmonary rehabilitation strategies for patients with COPD.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition characterized by persistent airflow limitation, chronic inflammation of the airways, and reduced lung function. It is commonly associated with long term exposure to harmful particles or gases, especially cigarette smoke. Patients with COPD often experience symptoms such as breathlessness, chronic cough, sputum production, and reduced exercise tolerance, which significantly affect their daily activities and overall quality of life. Pulmonary rehabilitation, particularly breathing exercises, plays an important role in the physiotherapy management of COPD.
Among the commonly used breathing techniques, pursed lip breathing is widely recommended for patients with COPD. This technique helps slow down expiration, prevents airway collapse, reduces air trapping, and improves ventilation efficiency. As a result, it may decrease dyspnea and enhance oxygen exchange. Another breathing technique, alternate nostril breathing, is a yogic breathing exercise that promotes better control of respiration, improves relaxation, and may enhance respiratory muscle coordination.
The purpose of this study is to investigate the effect of pursed lip breathing alone and in combination with alternate nostril breathing on patients with Grade I COPD. The study aims to determine whether the combined use of these breathing techniques can provide additional benefits compared to pursed lip breathing alone. By improving breathing patterns and respiratory mechanics, these interventions may help patients manage symptoms more effectively and enhance their functional capacity.
This research will follow an interventional study design in which participants will be divided into two groups. One group will receive pursed lip breathing exercises, while the second group will perform both pursed lip breathing and alternate nostril breathing. The intervention will be conducted over a specified period under proper supervision and guidance.
The findings of this study may contribute to the development of more effective physiotherapy based breathing exercise programs for patients with mild COPD and may support the integration of combined breathing techniques in pulmonary rehabilitation programs.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
FEV1
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in Group A will perform pursed lip breathing exercises. In this technique, patients are instructed to inhale slowly through the nose and then exhale slowly through pursed lips, as if blowing out a candle. The expiration phase is prolonged to help reduce air trapping and improve ventilation. The exercise will be performed under supervision for the prescribed duration and frequency during the intervention period.
Other: pursed lip breathing
Participants in Group B will perform a combination of pursed lip breathing and alternate nostril breathing. Along with PLB, patients will practice alternate nostril breathing, a controlled breathing technique in which inhalation and exhalation occur alternately through one nostril at a time while the other nostril is gently closed using the fingers. This technique helps regulate breathing patterns, improve respiratory control, and promote relaxation. The exercises will be performed under supervision according to the prescribed duration and frequency during the intervention period.
Other: Alternate Nostril breathing:
Alternate Nostril Breathing (ANB): Alternate nostril breathing is a controlled breathing technique commonly used in yogic practices to regulate breathing patterns. In this method, the individual inhales through one nostril while the other is closed, then exhales through the opposite nostril in an alternating pattern. This technique promotes relaxation, improves respiratory control, and may enhance lung function.
Alternate nostril breathing is a simple technique where you inhale through one nostril and exhale through the other in a controlled pattern. It helps calm the mind and improves lung function. This breathing exercise can be beneficial in conditions like Chronic Obstructive Pulmonary Disease. Practicing it regularly enhances relaxation and balances the body.
Pulmonary Function Test
Pulmonary function will be assessed using a calibrated spirometer to evaluate lung function parameters, including forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), and FEV₁/FVC ratio. The test will be performed according to standardized guidelines, with participants instructed to perform maximal inspiration followed by a forceful and sustained expiration into the spirometer.
Time frame: 04 weeks
Started Feb 2026 (actual). Primary completion is estimated for May 2026, 2 months after the start.
Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 2 months is below that.
Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Foundation University Islamabad →